Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaClinical Consult: Assessing the Impact of Tailor XColorectal CancerGastrointestinal CancerGastrointestinal Cancer QuizHead & Neck CancerHER2-Positive Breast CancerImmune Thrombocytopenic PurpuraLymphomaRenal Cell CarcinomaTelehealth

Brain CancerBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

All NewsNP/PAPractice ManagementTechnology

Expert InterviewsMedical World NewsTumor Board Series

CMEImage IQPodcastsPollsQuizzesSlideshows

eNewsletterPrint Subscription

Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences and Cancer Network. All rights reserved.

Spotlight

Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia
Clinical Consult: Assessing the Impact of Tailor X
Colorectal Cancer
Gastrointestinal Cancer
Gastrointestinal Cancer Quiz
Head & Neck Cancer
HER2-Positive Breast Cancer
Immune Thrombocytopenic Purpura
Lymphoma
Renal Cell Carcinoma
Telehealth

ClinicalSee All >

Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2020 MJH Life Sciences^™ and Cancer Network. All rights reserved.

Author | Elizabeth M. Swisher, MD

Articles

The Role of Rucaparib in Ovarian Cancer

March 14, 2017

We spoke with Dr. Elizabeth Swisher about the ARIEL2 trial and the role of rucaparib in ovarian cancer.